Slowing digestion, making you feel fuller for longer
Currently, there is no established causal relationship between semaglutide and colitis in the FDA-approved prescribing information or major clinical trials
Many cases settle out of court, but were always prepared to go to trial if necessary to secure fair compensation for our clients
In clinical trials: Semaglutide: Approximately 7% discontinued due to adverse events Tirzepatide: Approximately 4-7% discontinued due to adverse events (dose dependent) Retatrutide: Approximately 6-10% discontinued due to adverse events (dose dependent) These rates are relatively close, suggesting that despite the differences in mechanism and side effect profiles, all three medications are tolerable for the vast majority of people who start them
STUDIES ON THE PHYSIOLOGY OF SECRETIN: III
This phenomenon is often explained by the Glutathione Depletion-Methylation Cycle Block (GD-MCB) hypothesis , originally proposed to explain how Long COVID can trigger ME/CFS